Skip to content
Fundamentalis
Fundamentalis
Insightful market commentary from a fresh perspective.
  • Home
  • About Brian
  • Trinity Asset Management

Category: Biotech

Will The SP 500 see the Quarter-end Rally ?

June 8, 2022 Brian Gilmartin Leave a comment

Although not a technical analyst by training, the two price levels being watched for the SP 500 are the May…

Continue Reading →

Posted in: Biotech, Biotech sector / earnings, Technical Analysis, XBI

What is Worrisome about this Stock Market, and Where Readers Might Find Value

November 5, 2017 Brian Gilmartin Leave a comment

Two items read this week, were a little worrisome: 1.) Liz Ann Sonders, Schwab’s great strategist, posted this to Twitter…

Continue Reading →

Posted in: Bespoke, Biotech, Biotech sector / earnings, CME, EEM, Emerging Market ETF's (EEM, Emerging Markets, GS, Horan Capital, JPM, QQQ, SeeitMarket, stock market sentiment, Technology

Looking at Q4 ’17 Revisions, Expect a Strong Finish to 2017

July 29, 2017 Brian Gilmartin Leave a comment

Everyone and their brother is commenting on q2 ’17 SP 500 earnings results, and the numbers so far look good.…

Continue Reading →

Posted in: Amazon, Apple (AAPL), Biotech, Biotech sector / earnings, Weekly Earnings Update

SP 500 Weekly Earnings Update: The Treasury Market was Busy This Week – It’s the Rate of Change that Matters

March 5, 2017 Brian Gilmartin Leave a comment

The big news this week was the Treasury market and the rise in yields, but more on that in a…

Continue Reading →

Posted in: Biotech, Biotech sector / earnings, Health Care sector, TBF - inverse Treasury, Treasuries, Weekly Earnings Update

Q4 ’16 Earnings Now Less Important – Next 12 Months Could be more About P/E Expansion

November 12, 2016 Brian Gilmartin Leave a comment

Per Thomson Reuters, with 455 of the SP 500 having already reported their Q3 ’16 financial results, SP 500 earnings…

Continue Reading →

Posted in: Biotech, Biotech sector / earnings, PE expansion / contraction, Weekly Earnings Update, WMT

Post navigation

Page 1 of 4
1 2 … 4 Next →

Fundamentalis

  • Style-Box Update: Growth Still Leading Value Across Market-Caps: Zeroing in on Mid-Caps
  • SP 500 Earnings Update: The 10-year-and-Under Treasury Maturities Are Now All Below the Fed Funds Rate
  • No Question, the Monetary Policy (Interest Rate) Narrative Has Changed (For the Better)
  • Nike Earnings Preview: Some Improvement is Expected; The 7% Free-Cash-Flow Yield Helps
  • SP 500 Earnings Update: Q2 ’25 Earnings Should be Ok; The Attention Turns to Q3 ’25 Guidance

Subscribe to Fundamentalis

Loading

Archives

Copyright © 2025 Fundamentalis